COPD: Page 22

Non-antibiotic macrolides show potential for COPD treatment
New class of orally available macrolides demonstrates beneficial effects on inflammatory biomarkers.
April 13, 2024
Chronic obstructive pulmonary disease abstract concept vector illustration.
AI respiratory health monitoring system study gets underway
Researchers will examine the potential for AI and real-time sensors to improve patient care.
April 4, 2024
Image of Haile inhalor and phone app.
Human studies approved for lung denervation device
Potential treatment could be used for patients with COPD and asthma.
April 4, 2024
Graphic of doctor showing human lungs in hand.
Sponsored
Advocate for better air
Ascend Media
The ALA’s State of the Air report provides rankings and recommendations.
July 21, 2026
Advocate for better air
Potential therapies could bring paradigm shift to COPD treatment
Data and analytics company projects big changes in coming years.
March 29, 2024
Graphic of two doctors looking at a digital screen showing lungs.
Phase 1 trial begins for COPD treatment
Monoclonal antibody aimed at patients with moderate to severe COPD.
March 29, 2024
Image of a doctor writing on a clipboard with an out of focus woman in the background.
Three pharmaceutical companies cap prices on asthma, COPD inhalers
Move could make it easier to encourage patient compliance.
March 25, 2024
A woman using an inhaler outdoors.
Sponsored
Advocate for better air
Ascend Media
The ALA’s State of the Air report provides rankings and recommendations.
July 21, 2026
Advocate for better air
AstraZeneca begins phase III clinical trial on Breztri
THARROS trial will examine potential improvements in cardiopulmonary outcomes.
March 18, 2024
Image of scientist working in a laboratory setting, wearing safety goggles.
ALA releases new COPD Trends brief
Latest report underscores critical need for oxygen reform.
March 11, 2024
Older woman with oxygen tube in her nose.
First patient dosed in phase 2 COPD treatment trial
RLS-0071 is being tested for acute exacerbations of COPD in hospitalized patients.
March 11, 2024
Photo of an open book surrounded by medical equipment with the words COPD.
Sponsored
Pulmonary drug market forecast
Ascend Media
Review analysis, trends and predictions for pulmonary drug delivery systems, 2026 to 2035.
July 21, 2026
Pulmonary drug market forecast
Dupixent accepted for FDA priority review
The drug will be reviewed for treatment of COPD with type 2 inflammation.
March 4, 2024
Photo of blocks with FDA on them sitting on top of papers.
First patient tested in COPD ventilation system clinical trial
AeriSeal system shows promise in limiting collateral ventilation.
March 4, 2024
Photo of doctor with hand outstretched and graphic of lungs in his palm.
Gut microbiome plays pivotal role in COPD development
Research could pave the way for new treatments.
February 28, 2024
Photo of Phil Hansbro, PhD
Previous Page
Page 22 of 27
Next Page
Most Popular
Hidden immune cell unlocks novel SCLC treatment approach
Long-term impact of pediatric TB patients
Primary care initiative tackles asthma rescue inhaler overuse
Mepolizumab reduces systemic corticosteroid exposure in COPD patients
The overlooked burden of comorbidities in severe asthma care
COPD treatment falls short in phase 2 proof-of-concept trial